Related Experiment Video
Updated: Aug 18, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase
Elizabeth Johnston1, Kathryn M Dupnik, Matthew J Gonzales
1Division of Infectious Diseases, Stanford University, Stanford, CA, USA.
Abstract:
We have created a panel of recombinant HIV-1 infectious clones containing common patterns of reverse transcriptase (RT) mutations responsible for resistance to each of the currently available nucleoside reverse transcriptase inhibitors (NRTI), and we have submitted the panel to the National Institutes of Health AIDS Research and Reference Reagent Programme. Testing the activity of new antiretroviral compounds against this panel of drug-resistant clones will determine their relative activity against many clinically relevant NRTI-resistant viruses.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Viral Mutations
Antiviral Nucleoside Inhibitors

